Mycotoxins are metabolites produced by some forms of fungi and mold and are common in our environment at low levels. Health problems can arise when someone is exposed to inordinately high levels of mycotoxins or has physiologic difficulty clearing mycotoxins from their body.
[signup]
Mycotoxin-related illness is often overlooked and very difficult to diagnose. Although the list of possible symptoms associated with mycotoxin illness is both broad and long, there are scientific studies linking mycotoxin exposure to the following diseases:
- Peripheral neuropathy
- Chronic fatigue
- Chronic sinusitis
- Asthma
- Sarcoidosis
- Neurobehavioral dysfunction, such as difficulties with short-term memory, concentration, and executive function
Mycotoxin Facts
When narrowing down the need for mycotoxin testing, it is important to understand every patient’s home and work environment. Here are some statistics to keep in mind:
- Molds are very common in buildings and homes
- Mold will grow in places with a lot of moisture, such as around leaks in roofs, windows, or pipes or where there has been flooding
- People with allergies may be more sensitive to molds
- People with immune suppression or underlying lung disease are more susceptible to fungal infections and increased risk for infection from molds
How Do Practitioners Screen for Mycotoxins?
Low levels of mycotoxins are often found in the urine of healthy adults; therefore, urine is the most popular method of testing, although nasal secretions, sputum, or tissue biopsies can be used.
Urine mycotoxin testing is the best way to assess recent exposure to mycotoxins or how someone is clearing toxins from an internal reservoir of infection.
Things to Keep in Mind Prior to Testing
- Each lab uses its own values for what is considered a “normal” reference range for mycotoxins, so it’s essential to follow each lab’s standard ranges.
- Most labs recommend against using any sort of provoking agents before urinary mycotoxin testing (such as charcoal or glutathione) as they may raise the urinary levels of mycotoxins.
The Most Popular Mycotoxin Tests
Here are the most ordered mycotoxin tests:
MycoTOX
Mosaic Diagnostics (formerly Great Plains) offers the MycoTOX test, which uses a tried-and-true method for detecting mycotoxins known as advanced mass spectrometry combined with liquid chromatography (LC-MS). Numerous studies are validating LC-MS in the detection of mycotoxins.
Mosaic Diagnostics is unique in that it uses a method for creatinine correction on each individual sample. One key vulnerability in any urine test is the potential for dilution or concentration based on how much water someone has had to drink. Mosaic Diagnostics eliminates the variability associated with adjusting the sample in accordance with an individual’s urinary creatinine level. It can detect mycotoxin levels down to the parts per trillion (ppt).
Total Mycotoxin Panel
RealTime Laboratories offers a Total Mycotoxin Panel, which uses a unique method for mycotoxin detection. They created an ELISA immunoassay that detects the presence of mycotoxins in urine using antibodies directed to specific toxins. A validation study of this specific technique was published in the International Journal of Molecular Sciences in 2009. Real-Time Labs was recently granted a US patent for one of its mycotoxin tests.
It can detect mycotoxins down to 0.2 ppb for trichothecenes, 1.0 ppb for aflatoxins, and 2.0 ppb for ochratoxins.
Are These Tests Accredited?
Mosaic Diagnostics, and Real-Time - are CLIA-certified laboratories. CLIA stands for Clinical Laboratory Improvement Amendments and is the result of a 1988 congressional amendment that created quality and reliability standards for laboratories. CLIA certifications verify that the lab has met the quality and analytic standards necessary to ensure accurate and reliable results.
The CLIA standards do not address the clinical utility of a test. FDA approval of a test assures that the test has adequate clinical validation and that it is safe and effective at what it claims to test for. To date, there are no FDA-certified urinary mycotoxin tests.
[signup]
Summary
Mycotoxin-related illness can range from fatigue to long-lasting and severe neurologic deficits. As we experience more extreme weather with increased severity of flooding and storms, we can expect a subsequent increase in mycotoxin-related disease.
Clinical history and professional experience play a huge role in the diagnosis and management of mycotoxin-related illnesses. Keep in mind that there remains clinical controversy on what reference ranges to use for mycotoxin testing, so it’s essential to follow each lab’s standard ranges.
Mycotoxins are substances made by some types of fungi and mold, and they are commonly found in our environment at low levels. Health concerns may arise when someone is exposed to very high levels of mycotoxins or has difficulty processing them in their body.
[signup]
Mycotoxin-related health issues can be challenging to identify. Although the list of possible symptoms associated with mycotoxin exposure is broad, some scientific studies have explored links between mycotoxin exposure and certain health conditions, such as:
- Peripheral neuropathy
- Chronic fatigue
- Chronic sinusitis
- Asthma
- Sarcoidosis
- Neurobehavioral challenges, such as difficulties with short-term memory, concentration, and executive function
Mycotoxin Facts
When considering the need for mycotoxin testing, it is important to understand each person’s home and work environment. Here are some points to keep in mind:
- Molds are very common in buildings and homes
- Mold can grow in places with a lot of moisture, such as around leaks in roofs, windows, or pipes, or where there has been flooding
- People with allergies may be more sensitive to molds
- People with weakened immune systems or underlying lung conditions may be more susceptible to fungal infections and increased risk from molds
How Do Practitioners Screen for Mycotoxins?
Low levels of mycotoxins are often found in the urine of healthy adults; therefore, urine is a common method of testing, although nasal secretions, sputum, or tissue samples can also be used.
Urine mycotoxin testing can help assess recent exposure to mycotoxins or how someone is processing these substances from their body.
Things to Keep in Mind Prior to Testing
- Each lab uses its own values for what is considered a “normal” reference range for mycotoxins, so it’s important to follow each lab’s standard ranges.
- Most labs recommend against using any sort of provoking agents before urinary mycotoxin testing (such as charcoal or glutathione) as they may affect the urinary levels of mycotoxins.
The Most Popular Mycotoxin Tests
Here are some commonly ordered mycotoxin tests:
MycoTOX
Mosaic Diagnostics (formerly Great Plains) offers the MycoTOX test, which uses a method for detecting mycotoxins known as advanced mass spectrometry combined with liquid chromatography (LC-MS). Numerous studies support the use of LC-MS in the detection of mycotoxins.
Mosaic Diagnostics uses a method for creatinine correction on each individual sample. One key consideration in any urine test is the potential for dilution or concentration based on how much water someone has had to drink. Mosaic Diagnostics addresses this by adjusting the sample in accordance with an individual’s urinary creatinine level. It can detect mycotoxin levels down to the parts per trillion (ppt).
Total Mycotoxin Panel
RealTime Laboratories offers a Total Mycotoxin Panel, which uses a method for mycotoxin detection. They created an ELISA immunoassay that detects the presence of mycotoxins in urine using antibodies directed to specific toxins. A validation study of this technique was published in the International Journal of Molecular Sciences in 2009. Real-Time Labs was recently granted a US patent for one of its mycotoxin tests.
It can detect mycotoxins down to 0.2 ppb for trichothecenes, 1.0 ppb for aflatoxins, and 2.0 ppb for ochratoxins.
Are These Tests Accredited?
Mosaic Diagnostics and Real-Time Laboratories are CLIA-certified. CLIA stands for Clinical Laboratory Improvement Amendments and is the result of a 1988 congressional amendment that created quality and reliability standards for laboratories. CLIA certifications verify that the lab has met the quality and analytic standards necessary to ensure accurate and reliable results.
The CLIA standards do not address the clinical utility of a test. FDA approval of a test assures that the test has adequate clinical validation and that it is safe and effective at what it claims to test for. To date, there are no FDA-certified urinary mycotoxin tests.
[signup]
Summary
Mycotoxin-related health issues can range from fatigue to more severe challenges. As we experience more extreme weather with increased flooding and storms, there may be a rise in mycotoxin-related concerns.
Clinical history and professional experience play a significant role in understanding and managing mycotoxin-related health issues. Keep in mind that there is ongoing discussion about what reference ranges to use for mycotoxin testing, so it’s important to follow each lab’s standard ranges.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
A S Laney 1, L. A.-G. (2009, February). Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/19191928/
Basic Facts about Mold and Dampness. (2020, August 11). Retrieved from CDC.gov: https://www.cdc.gov/mold/faqs.htm
Campbell, A., Thrasher, J., Madison, R., Vojdani, A., Gray, M., & Johnson, A. (2010, August 07). Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in Water-Damaged Buildings. Retrieved from Taylor & Francis Online: https://www.tandfonline.com/doi/abs/10.3200/AEOH.58.8.464-474
Dennis, D. P. (2003, July). Chronic sinusitis: defective T-cells responding to superantigens, treated by reduction of fungi in the nose and air. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/15143856/
Emmanuel Njumbe Ediage, J. D. (2012, September). A direct assessment of mycotoxin biomarkers in human urine samples by liquid chromatography tandem mass spectrometry. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/22840705/
Hooper, D. G., Bolton, V. E., Guilford, F. T., & Straus, D. C. (2009). Mycotoxin detection in human samples from patients exposed to environmental molds. International Journal of Molecular Sciences, 10(4), 1465–1475. https://doi.org/10.3390/ijms10041465
J Ahn 1, D. K.-Y. (2010, December). Quantitative determination of mycotoxins in urine by LC-MS/MS. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/20818517/
Joseph H Brewer 1, J. D. (2013, April 11). Detection of mycotoxins in patients with chronic fatigue syndrome. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/23580077/
Joseph H. Brewer, J. D. (2013, December). Chronic Illness Associated with Mold and Mycotoxins: Is Naso-Sinus Fungal Biofilm the Culprit? Retrieved from US National Library of Medicine National Institutes of Health: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920250/
Kilburn, K. H. (2003, Jul). Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/15143851/
Melody Kawamoto, M. E. (2015, February 20). Use of Unvalidated Urine Mycotoxin Tests for the Clinical Diagnosis of Illness — United States, 2014. Retrieved from CDC.gov: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a7.htm
William J Rea 1, N. D. (2003, July). Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Retrieved from Pubmed.gov: https://pubmed.ncbi.nlm.nih.gov/15143852/
%201.svg){kind=logo}
